Shen L - Search Results

1

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.

Li J, Xu R, Xu J, Denda T, Ikejiri K, Shen L, Toh Y, Shimada K, Kato T, Sakai K, Yamamoto M, Mishima H, Wang J, Baba H. Li J, et al. Among authors: shen l. Cancer Sci. 2017 Oct;108(10):2045-2051. doi: 10.1111/cas.13335. Epub 2017 Sep 9. Cancer Sci. 2017. PMID: 28763145 Free PMC article. Clinical Trial.

2

[The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer].

Zhang XD, Shen L, Li Y, Li J, Yang BQ, Jin ML. Zhang XD, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):289-91. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12839698 Chinese.

3

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L. Gong JF, et al. Among authors: shen l. Ai Zheng. 2007 Aug;26(8):890-4. Ai Zheng. 2007. PMID: 17697554 Free article. Chinese.

4

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.

Zhang X, Shen L, Li J, Li Y, Li J, Jin M. Zhang X, et al. Among authors: shen l. Am J Clin Oncol. 2008 Feb;31(1):29-33. doi: 10.1097/COC.0b013e3181131ca9. Am J Clin Oncol. 2008. PMID: 18376224 Clinical Trial.

5

[Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients].

Wang Y, Xu JM, Shen L, Xu N, Wang JW, Jiao SC, Zhang JS, Song ST, Li J, Bao HY, Yang L, Li F. Wang Y, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):913-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478930 Chinese.

6

[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].

Li J, Xu JM, Li J, Zhang XD, Bai Y, Chu YP, Wang YH, Liu DQ, Jin ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):225-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756942 Clinical Trial. Chinese.

7

[Cetuximab in combination with chemotherapy for patients with gastrointestinal cancer].

Zhang XT, Shen L, Zhang XD, Li J, Zhang ZT. Zhang XT, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):385-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953842 Chinese.

8

[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

Zhang J, Xiao Y, Lu M, Li J, Zhang XD, Li Y, Shen L. Zhang J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):312-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615292 Chinese.

9

[Oxaliplatin-based regimen for the treatment of advanced or metastatic gastric/esophagogastric junction cancer].

Li J, Lu M, Shen L, Zhang XD, Li Y. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):933-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20193337 Chinese.

10

EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients.

Li YH, Wang F, Shen L, Deng YM, Shao Q, Feng F, An X, Wang FH, Wang ZQ, Xu RH, Shao JY. Li YH, et al. Among authors: shen l. Clin Cancer Res. 2011 Jan 15;17(2):382-90. doi: 10.1158/1078-0432.CCR-10-0208. Epub 2010 Sep 30. Clin Cancer Res. 2011. PMID: 20884623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,647 results

Search Page

Filters